Strengths and limitations of PSMA PET: When to use it (and when not to)
November 26, 2021Read moreThe prostate-specific membrane antigen positron emission tomography (PSMA PET) scan is the (relatively) new kid on the block in...
10
Expectations for new WHO classification and what’s next in PCa grading
November 25, 2021Read moreThe EMUC Symposium on Genitourinary Pathology and Molecular Diagnostics (ESUP) delivered updates and expert insights on topics such as...
Definitive: EMUC21 is coming to Athens!
September 24, 2021Read moreNew crucial updates in GU cancer prevention, diagnosis and management Relive and enjoy the congress experience, meet and connect...
Radioligand therapy: multidisciplinary collaboration for health system readiness
September 13, 2021Read moreBy the European Society for Medical Oncology (ESMO) team Join the EMUC21 session ‘Radioligand therapy: multidisciplinary collaboration for health...
New developments in imaging have great potential to change treatment in the coming years
November 14, 2020Read moreThere are several promising imaging techniques on the horizon, with the potential of changing the way oncology experts treat...
EMUC20: Highlights in GU cancers
November 13, 2020Read moreActive surveillance should be considered the first treatment for prostate cancer in order to ensure the best quality of...
Getting EMUC20 ready for a virtual audience
October 7, 2020Read moreEMUC20 is going ahead this year as an online-only Virtual Congress, to be held on 13 and 14 November....
12th EMUC celebrates longstanding ties between societies
May 11, 2020Read moreThe EAU, the European Society for Medical Oncology (ESMO) and the European SocieTy for Radiotherapy & Oncology (ESTRO) are...
Imaging and pathology: The harm of false positives
November 16, 2019Read more“A false positive can really change the life of a patient so we should only make a diagnosis if...
